What is the incubation period for Middle East Respiratory Syndrome coronavirus (MERS-CoV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MERS-CoV Incubation Period

The incubation period for Middle East Respiratory Syndrome coronavirus (MERS-CoV) ranges from 2 to 14 days, with a median of approximately 5 days. 1

Evidence-Based Incubation Period Estimates

The most robust data comes from multiple research studies examining MERS-CoV cases:

  • Primary estimate: The incubation period begins after an exposure and typically lasts 2 to 14 days, with a median of 4-5 days 1

  • Geographic variation exists: A comparative study found the mean incubation period was 5.0 days (95% CI: 4.0-6.6) in Saudi Arabia versus 6.9 days (95% CI: 6.3-7.5) in South Korea 2. This 1.42-fold difference may reflect variations in exposure routes, reporting practices, or environmental factors.

  • Hospital outbreak data: During a documented healthcare facility outbreak in Saudi Arabia, the median incubation period was estimated at 5.2 days (95% CI: 1.9-14.7) 3

  • Nosocomial transmission: In a French hospital case involving person-to-person transmission, the incubation period was estimated at 9-12 days for the secondary case 4

Clinical Implications for Quarantine and Monitoring

Use a 14-day observation period for all exposed individuals, starting from the last day of contact with a confirmed MERS-CoV patient or contaminated environment 4. This maximum incubation period ensures capture of late-developing cases.

Key monitoring points:

  • Fever typically appears first, often without respiratory symptoms initially
  • Respiratory symptoms (cough, dyspnea) develop subsequently
  • Some patients may remain asymptomatic despite infection

Important Clinical Caveat

The incubation period correlates with disease severity: Longer incubation periods are associated with reduced mortality risk (adjusted OR 0.83 per 1-day increase, 95% CI: 0.68-1.03) 5. This suggests that patients who develop symptoms rapidly after exposure may experience more severe disease courses.

Practical Application

For contact tracing and public health surveillance:

  • Minimum monitoring: 5 days post-exposure for early symptom detection
  • Standard quarantine: 14 days post-exposure to capture all potential cases
  • High-risk contacts (healthcare workers, household members): Monitor closely during days 2-7 when symptom onset is most likely

The 14-day maximum remains the standard for defining epidemiologic risk in case definitions and determining appropriate isolation periods 4, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.